Medical supervision included in our programs provides comprehensive initial evaluation and ongoing monitoring, dose adjustments based on your response and tolerance, side effect management and troubleshooting, lab work coordination when needed, and nutrition and lifestyle guidance
Patients should be advised to: Eat smaller, more frequent meals rather than large portions Choose bland, easily digestible foods during the initial treatment period Avoid high-fat, fried, or heavily spiced foods that may exacerbate nausea Stay well hydrated, sipping water throughout the day Limit alcohol and caffeine intake Eat slowly and chew food thoroughly Dose titration plays a crucial role in minimising side effects
Always discuss supplementation with your healthcare provider before starting, especially if you take medications or manage ongoing health conditions
These options have different evidence bases, mechanisms, and adverse-effect profiles from KLOW
Acute peripheral administration of synthetic human GLP-1 (7-36 amide) decreases circulating IL-6 in obese patients with type 2 diabetes mellitus: a potential role for GLP-1 in modulation of the diabetic pro-inflammatory state
For private insurance, we recommend contacting your benefits administrator with your details and the Drug Identification Number (DIN) and the drug name to determine your coverage
